First Time Loading...

Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 19.75 USD 2.33% Market Closed
Updated: May 15, 2024

P/S
Price to Sales

8.3
Current
21.9
Median
8.2
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
8.3
=
Market Cap
2.7B
/
Revenue
330.5m
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
29.5
2-Years Forward
P/S
14.3
3-Years Forward
P/S
11.2

See Also

Discover More